Bots, editor, reviewer, Administrators
13,951
edits
WikiJournalClub:Usable articles: Difference between revisions
Jump to navigation
Jump to search
WikiJournalClub:Usable articles (view source)
Revision as of 01:06, 29 January 2016
, 29 January 2016no edit summary
No edit summary |
No edit summary |
||
| Line 384: | Line 384: | ||
* [[EDIC]] (2005): Intensive glycemic therapy in T1DM | * [[EDIC]] (2005): Intensive glycemic therapy in T1DM | ||
* [[EMPA-REG OUTCOME]] (2015): Empagliflozin for CV outcomes in T2DM | * [[EMPA-REG OUTCOME]] (2015): Empagliflozin for CV outcomes in T2DM | ||
* [[IDNT]] (2001): ARBs in diabetic nephropathy | |||
* [[Look AHEAD]] (2013): Weight loss and exercise in T2DM | * [[Look AHEAD]] (2013): Weight loss and exercise in T2DM | ||
* [[ONTARGET]] (2008): Ramipril vs. telmisartan vs. both in CVD, stroke, PAD, or DM | * [[ONTARGET]] (2008): Ramipril vs. telmisartan vs. both in CVD, stroke, PAD, or DM | ||
| Line 396: | Line 397: | ||
'''Diabetic Nephropathy''' | '''Diabetic Nephropathy''' | ||
* [[CSG Captopril Trial]] (1993): Captopril in T1DM nephropathy | * [[CSG Captopril Trial]] (1993): Captopril in T1DM nephropathy | ||
* [[IDNT]] (2001): ARBs in diabetic nephropathy | |||
* [[VA-NEPHRON D]] (2013): ACE+ARB in DM nephropathy | * [[VA-NEPHRON D]] (2013): ACE+ARB in DM nephropathy | ||
| Line 604: | Line 606: | ||
'''Diabetes Mellitus''' | '''Diabetes Mellitus''' | ||
* [[CSG Captopril Trial]] (1993): Captopril in T1DM nephropathy | * [[CSG Captopril Trial]] (1993): Captopril in T1DM nephropathy | ||
* [[IDNT]] (2001): ARBs in diabetic nephropathy | |||
* [[ONTARGET]] (2008): Ramipril vs. telmisartan vs. both in CVD, stroke, PAD, or DM | * [[ONTARGET]] (2008): Ramipril vs. telmisartan vs. both in CVD, stroke, PAD, or DM | ||
* [[RENAAL]] (2001): ARBs in diabetic nephropathy | * [[RENAAL]] (2001): ARBs in diabetic nephropathy | ||
| Line 611: | Line 614: | ||
'''Diabetic Nephropathy''' | '''Diabetic Nephropathy''' | ||
* [[CSG Captopril Trial]] (1993): Captopril in T1DM nephropathy | * [[CSG Captopril Trial]] (1993): Captopril in T1DM nephropathy | ||
* [[IDNT]] (2001): ARBs in diabetic nephropathy | |||
* [[VA-NEPHRON D]] (2013): ACE+ARB in DM nephropathy | * [[VA-NEPHRON D]] (2013): ACE+ARB in DM nephropathy | ||
| Line 694: | Line 698: | ||
* [[ROCKET AF]] (2011): Rivaroxaban vs. warfarin in AF | * [[ROCKET AF]] (2011): Rivaroxaban vs. warfarin in AF | ||
* [[SPARCL]] (2006): Atorvastatin after stroke | * [[SPARCL]] (2006): Atorvastatin after stroke | ||
* [[SPS3-BP]] (2013): SBP <130 vs. SBP 130-150 after lacunar strokes | |||
'''Transient Ischemic Attack''' | '''Transient Ischemic Attack''' | ||